A safe and affordable treatment to slow the advancement of Parkinson's dementia has emerged – in the form of a commonly ...

Ambroxol, long used for coughs in Europe, stabilized symptoms and brain-damage markers in Parkinson’s dementia patients over ...

A COMMON cough medicine could help protect against dementia. A study found that it prevented people with Parkinson’s develop ...

A common cough syrup, Ambroxol, has shown potential in slowing the progression of Parkinson's dementia in a recent clinical trial.

Ambroxol chaperones GCase; in a previous study of people with Parkinson's disease, the drug led to increased GCase levels. It ...

Dementia poses a major health challenge with no safe, affordable treatments to slow its progression. Researchers at Lawson ...

Common cough medicine revealed to slow down Parkinson's disease and dementia - A 12-month study found that Ambroxol helped stabilised psychiatric symptoms and protected against brain damage in genetic ...

A commonly sold cough syrup in Europe could potentially slow down progression of dementia in patients with Parkinson’s disease, a new study suggests.Nearly half of those diagnosed with Parkinson’s ...

Ambroxol supports a key enzyme called glucocerebrosidase (GCase), which is produced by the GBA1 gene. In people with Parkinson's disease, GCase levels are often low.

Ambroxol supports a key enzyme called glucocerebrosidase (GCase), which is produced by the GBA1 gene. In people with Parkinson’s disease, GCase levels are often low.

A clinical trial has revealed that Ambroxol, a common cough medicine in Europe, may help slow cognitive decline in people with Parkinson’s disease dementia.

A cough medicine used for decades in Europe called Ambroxol has shown promise for treating dementia in people with ...